增强现实用于手术导航:经皮肿瘤消融先进针引导系统综述
经皮肿瘤消融常依赖二维超声或CT引导,术者需将二维屏幕图像在脑中转换为三维解剖。增强现实(AR)导航系统可提供患者解剖的三维视图,有望消除这种心理转换。本文综述市售经皮手术导航平台,讨论AR导航系统的潜在优势、采用挑战和未来发展。
要点
- 传统二维超声或CT引导需术者将屏幕图像心理转换为三维解剖。
- 先进导航系统常融合多种成像模态以规划针道并避开关键结构。
- AR系统可提供三维解剖视图,可能消除术者心理转换的需要。
核心结论
- AR导航系统有潜力提供患者解剖的三维视图,消除术者心理转换的需要,但采用仍面临挑战。
研究设计与样本
- 综述,回顾市售先进经皮手术导航平台并讨论AR导航系统现状,未报告系统检索范围与纳入文献数量。
临床应用与阅片要点
- 本文讨论AR导航系统的潜在优势、采用挑战和未来发展,原文未据此给出具体阅片或报告推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Percutaneous tumor ablation has become a widely accepted and used treatment option for both soft and hard tissue malignancies. The current standard-of-care techniques for performing these minimally invasive procedures require providers to navigate a needle to their intended target using two-dimensional (2D) US or CT to obtain complete local response. These traditional image-guidance systems require operators to mentally transpose what is visualized on a 2D screen into the inherent three-dimensional (3D) context of human anatomy. Advanced navigation systems designed specifically for percutaneous needle-based procedures often fuse multiple imaging modalities to provide greater awareness and planned needle trajectories for the avoidance of critical structures. However, even many of these advanced systems still require mental transposition of anatomy from a 2D screen to human anatomy. Augmented reality (AR)-based systems have the potential to provide a 3D view of the patient's anatomy, eliminating the need for mental transposition by the operator. The purpose of this article is to review commercially available advanced percutaneous surgical navigation platforms and discuss the current state of AR-based navigation systems, including their potential benefits, challenges for adoption, and future developments. Keywords: Computer Applications-Virtual Imaging, Technology Assessment, Augmented Reality, Surgical Navigation, Percutaneous Ablation, Interventional Radiology ©RSNA, 2025.
引用
- Evans M, Kang S, Bajaber A, et al. Augmented Reality for Surgical Navigation: A Review of Advanced Needle Guidance Systems for Percutaneous Tumor Ablation. Radiol Imaging Cancer. 2025. PMID: 39750112. doi:10.1148/rycan.230154
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。